Safety and efficacy study of submicronized aerosols of sodium nitrite respiratory fluid against smoke induced oxidative stress and lung injuries

International Journal of Drug Development and Research

Volumn 4, Issue 2, 2012, Pages 358-368

  Rashid, Ali ^a   Gaurav, Mittal ^a   Lal, Soni Nakse ^a   Bhavna, ^a   Krishan, Sawroop ^a   Sarwat, Sultana ^b   Aseem, Bhatnagar ^a  

^a INSTITUTE OF NUCLEAR MEDICINE AND ALLIED SCIENCES   (India)

^b HAMDARD UNIVERSITY   (India)

Author keywords

Bronchoalveolar lavage fluid (bal); Histopathology; Nebulization; Sodium nitrite; Subacute safety

Indexed keywords

SODIUM NITRITE;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; HISTOPATHOLOGY; LUNG BURN; LUNG EDEMA; LUNG LAVAGE; MALE; MICROVASCULATURE; NEBULIZATION; NECROSIS; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; RAT; RESPIRATORY EPITHELIUM; VASODILATATION;

EID: 84870168264     PISSN: None     EISSN: 09759344     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Bhavna, Ahmad FJ, Mittal G, Jain GK, Malhotra G, Khar RK, Bhatnagar A. Nano-salbutamol dry powder inhalation: A new approach for treating broncho-constrictive conditions. Eur. J. Pharmaceut. Biopharmaceut. 2009; 71: 282-291.
2. Ali R, Jain GK, Iqbal Z, Talegaonkar S, Pandit P, Sule S, Malhotra G, Khar RK, Bhatnagar A, Ahmad FJ. Development and clinical trial of nano-atropine sulfate dry powder inhaler as a novel organophosphorous poisoning antidote. Nanomedicine: NBM. 2009; 5: 55-63.
3. Rodrigo GJ. Inhaled therapy for acute adult asthma. Curr. Opin. Allergy Clin. Immuno. 2003; 3: 169-175.
4. Borm, PJA, Robbins D, Haubold S. The potential risks of nanomaterials: a review carried out for ECETOC. Part Fibre Toxicol. 2006; 3-11.
5. Nel A, Xia T, Madler L, Li N. Toxic potential of materials at the nanolevel. Science. 2006; 311: 622-627.
6. Schreiber MD, Dixit R, Rudinsky B, Hipps R, Morgan SE, Keith RRTA. Direct comparison of the effects of nebulized nitroprusside versus inhaled nitric oxide on pulmonary and systemic hemodynamics during hypoxia induced pulmonary hypertension in piglets. Crit. Care Med. 2002; 30: 2560-2565.
7. Xia HP, Huang GY, Sun B, Chen C. Effects of nebulized nitric oxide donors on acute hypoxic pulmonary hypertension in newborn piglets. Chin. J. Emerg. Med. 2006; 15: 117-120.
8. Hubbard GB, Langlinais PC, Shimazu T, Okerberg CV, Mason AD, Pruitt BA. The morphology of smoke inhalation injury in sheep. J Trauma. 1991; 31:1477-1486.
9. Patel KR, Pavia D, Lowe L, Spiteri M. Inhaled ethanolic and aqueous solutions via Respimat Soft Mist Inhaler are well-tolerated in asthma patients. Respiration. 2006; 73: 434-440.
10. Henderson RF, Benson JM, Hahn FF, Hobbs CH, Jones RK, Mauderly JL. New approaches for the evaluation of pulmonary toxicity: bronchoalveolar lavage. Toxicol. Sci. 1985; 5: 451-458.
11. Reynolds HY. Bronchoalveolar lavage, Am. Rev. Respir. Dis. 1987; 135: 250-263.
12. Sole PD, Pagliari G, Napolitano M, Frigeri L, Delia C, Anna M, Marzo AD, Valentini S, D'Onofrio G. Cell count in bronchoalveolar lavage fluid: comparison between counting chamber and two automatic cell counters. J. Bronch. Interven. Pulmonol. 1996; 3: 192-195.
13. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976; 72: 248-254.
14. Henderson RF, Scott GG, Waide JJ. Source of alkaline phosphatase activity in epithelial lining fluid of normal and injured F344 rat lungs. Toxicol. Appl. Pharmacol. 1995; 57: 170-174.
15. Kornberg A. Lactic dehydrogenase of muscle, in: S.P. Colowick, N.O. Kaplan (Eds.), Methods in Enzymology, Academic Press, New York, 1955; 441-443.
16. Ji JH, Jung JH, Kim SS, Yoon JU, Park JD, Choi BS, Chung YH. Twenty eight day inhalation toxicity study of silver nanoparticles in Sprague dawley rats. Inhalation Toxicol. 2007: 10:857-871.
17. Costabel U, Guzman J. Bronchoalveolar lavage in interstitial lung disease. Curr. Opin. Pulm. Med. 2001; 7: 255-261.
18. Reynolds HY. Use of bronchoalveolar lavage in humans--past necessity and future imperative. Lung. 2000; 178: 271-293.
19. Reynolds HY. Bronchoalveolar lavage: perspective from the 11th BAL Conference, Monaldi. Arch. Chest Dis. 2008; 69: 91-93.